Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer
Abstract Introduction: The Bystin gene (BYSL) contributes to cancer development and is a probable therapeutic target in cancer therapy. However,…
Abstract Introduction: The Bystin gene (BYSL) contributes to cancer development and is a probable therapeutic target in cancer therapy. However,…
Abstract Background: Papillary thyroid carcinoma (PTC) is a common malignancy with a good prognosis, but lymph node metastasis (LNM) is…
Abstract Background: With the sharp increase in the incidence of papillary thyroid carcinoma (PTC), the disease-specific survival rate has not…
Abstract Background: USP37, a versatile deubiquitinase, plays a pivotal role in numerous cellular functions. Although its involvement in cancer development…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-025-16737-4. Article type: Research Article Keywords: GDF-15, Stemness, Diagnosis,…
Abstract Background: Hepatocellular carcinoma (HCC) is a prevalent lethal cancer that remains challenging to treat. Therefore, investigation of novel targets…
Abstract Ubiquitin-conjugating enzyme 2T (UBE2T) constitutes a critical component of the ubiquitin-proteasome system and is involved in tumorigenesis. The UBE2T…
Abstract Background: As a cell adhesion factor, cluster of differentiation 99 (CD99) mainly plays a role in regulating cell differentiation.…
Abstract Background: GPCRs play an important role in the development of cancer. However, as a member of the G protein-coupled…
Abstract Background: Nucleoporin 188 (NUP188) is a vital component of the nuclear pore complex that regulates cancer progression, but its…